MedTrace Logo

Blood Sample Collection for Experimental Blood Test to Track Liver Cancer

NCT04720430 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 7

Last updated 2025-04-29

No results posted yet for this study

Summary

This study investigates if an experimental blood test can help predict how well cancer will remain under control with treatment. Ther experimental blood test involves measuring mircoRNAs. MicroRNAs are small molecules which help regulate how genes are expressed. This information may help researchers guide treatment for other patients in the future.

Conditions

Sponsors & Collaborators

  • Thomas Jefferson University

    lead OTHER

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2019-12-03
Primary Completion
2023-02-15
Completion
2023-11-09

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04720430 on ClinicalTrials.gov